In focus · trending topic

Dry Eye Treatments

3 stories · following the connections

I-MED Pharma’s I-PEN® Receives Regulatory Approval from INVIMA in Colombia and ANMAT in Argentina

By Nasdaq OMXApr 3, 2018, 6:30 PM UTC

I-MED Pharma's I-PEN® Does Not Infringe the TearLab Patent

By Nasdaq OMXFeb 20, 2018, 8:44 PM UTC

I-MED Pharma partners with OCuSOFT to bring the I-PEN® Osmolarity System to the U.S.A.

By Nasdaq OMXJan 8, 2018, 6:02 PM UTC